Company: RCUS
Filing Date: 2025-04-22
Form Type: DEF 14A
Source: 0001724521-25-000052
Chunk: 53

Company: Arcus Biosciences, Inc.
Filing Date: 2025-04-22
Form: DEF 14A
Chunk 53
---
 stock units on the date of grant, computed in accordance with FASB ASC Topic 718. The valuation assumptions used in determining fair values for restricted stock unit awards are described in Note 8 to our financial statements included in our Annual Report.

(2) The amount represents the aggregate grant date fair value of stock options computed in accordance with FASB ASC Topic 718. The valuation assumptions used in determining fair values for option awards are described in Note 8 to our financial statements included in our Annual Report.

(3) Dr. Nuyten terminated employment with us on January 31, 2025.

(4) The amount includes $7,144 life insurance premiums paid by the company for the executive's benefit and $5,000 in 401(k) matching contributions.

(5) The amount includes $250,000 severance payment and $5,000 in 401(k) matching contributions.

<div align='center'>29.</div>

#### 2024 Grants of Plan-Based Awards
The following table shows certain additional information regarding grants of plan-based awards to our named executive officers for the 2024 fiscal year:

|                      |     |            |     |           |            |     |           |     |   |     | Estimated Future Payouts Under Non-Equity Incentive Plan Awards(1) |   |     |         |     |        |   |     |   |     |         |   |     |         |     | All Other Stock Awards:     
 Number of                   
 Shares of Stock or Units(2) |   |     |   |     | All Other Option      
 Awards: Number of     
 Securities Underlying 
 Options(3)            |         |     |   |     | Exercise or Base Price of 
 Option Award              |       |     |           |     | Grant-Date Fair Value of  
 Stock and Option Award(4) |           |
| Name                 |     | Award Type |     |           | Grant Date |     |           |     |   |     | Threshold                                                          
 ($)                                                                |   |     |         |     | Target 
 ($)    |   |     |   |     | Maximum 
 ($)     |   |     |         |     | -

#                          |   |     |   |     | -#                    |         |     |   |     | -$ per share              |       |     |           |     | -$                        |           |
| Terry Rosen, Ph.D.   |     | Option     |     |